Mood Disorders in Head and Neck Cancer Patients

NCT04977271 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped study never opened

Conditions

Depressive Disorder
Head and Neck Cancer

Interventions

DRUG: Venlafaxine

Sponsor

University of Alabama at Birmingham